Ross T Campbell Selected Research

Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)

1/2023

Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ross T Campbell Research Topics

Disease

23	Heart Failure 05/2024 - 12/2012
5	Myocardial Infarction 05/2024 - 01/2021
3	Left Ventricular Dysfunction 05/2024 - 01/2021
2	Cardiomyopathies (Cardiomyopathy) 05/2024 - 01/2021
2	Stroke (Strokes) 03/2024 - 09/2023
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2021
2	Prediabetic State (Prediabetes) 01/2022 - 01/2021
2	Hypertension (High Blood Pressure) 11/2021 - 12/2012
2	Fibrosis (Cirrhosis) 11/2021 - 10/2021
2	Diabetes Mellitus 01/2021 - 12/2012
1	Transient Ischemic Attack 03/2024
1	Chronic Obstructive Pulmonary Disease (COPD) 03/2024
1	COVID-19 09/2023
1	Infections 09/2023
1	Acute Kidney Injury (Acute Renal Failure) 09/2023
1	Ischemic Stroke 01/2023
1	Infarction (Infarctions) 01/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2022
1	Pathologic Processes 11/2021
1	Inflammation (Inflammations) 11/2021
1	Ventricular Remodeling 01/2021
1	Cardiotoxicity 02/2013
1	Atrial Fibrillation 12/2012
1	Angina Pectoris 12/2012
1	Chest Pain (Chest Pains) 12/2011

Drug/Important Bio-Agent (IBA)

5	Brain Natriuretic Peptide (Natrecor)FDA Link 03/2024 - 12/2011
5	pro-brain natriuretic peptide (1-76)IBA 03/2024 - 01/2020
4	dapagliflozinIBA 05/2024 - 01/2023
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 12/2019
3	empagliflozinIBA 05/2024 - 01/2021
3	Neprilysin (Neutral Endopeptidase)IBA 03/2024 - 01/2021
3	Irbesartan FDA LinkGeneric 03/2024 - 12/2012
3	Sodium-Glucose Transport ProteinsIBA 03/2024 - 01/2021
3	Furosemide (Lasix)FDA LinkGeneric 02/2024 - 01/2023
3	DiureticsIBA 01/2023 - 01/2021
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 03/2024 - 01/2021
2	Mineralocorticoid Receptor AntagonistsIBA 12/2023 - 12/2019
2	SugarsIBA 01/2022 - 01/2021
2	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2021 - 01/2021
2	candesartanIBA 12/2019 - 12/2012
1	Sodium-Glucose Transporter 2 InhibitorsIBA 05/2024
1	paragonIBA 03/2024
1	CreatinineIBA 03/2024
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2024
1	Angiotensin Receptor AntagonistsIBA 01/2024
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 09/2023
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2023
1	ThiazidesIBA 01/2023
1	Endothelin-1 (Endothelin 1)IBA 01/2023
1	SaltsIBA 01/2023
1	Metolazone (Diulo)FDA LinkGeneric 01/2023
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2023
1	CollagenIBA 11/2021
1	Peptides (Polypeptides)IBA 11/2021
1	GadoliniumIBA 10/2021
1	Valsartan (Vals)FDA Link 01/2021
1	SympatholyticsIBA 01/2021
1	Ramipril (Altace)FDA LinkGeneric 01/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2015
1	Fluorouracil (Carac)FDA LinkGeneric 02/2013

Therapy/Procedure

2	Therapeutics 01/2023 - 06/2015
2	Palliative Care (Palliative Therapy) 01/2018 - 03/2015
1	Infusion Pumps (Infusion Pump) 10/2023
1	Artificial Respiration (Mechanical Ventilation) 09/2023
1	Renal Replacement Therapy (Therapies, Renal Replacement) 09/2023
1	Secondary Prevention 01/2023
1	Drug Therapy (Chemotherapy) 01/2016